132972-30-6Relevant articles and documents
Novel hybrids derived from aspirin and chalcones potently suppress colorectal cancer in vitro and in vivo
Lu, Shan,Obianom, Obinna N.,Ai, Yong
, p. 1722 - 1732 (2018/10/26)
Colorectal cancer (CRC) remains the fourth leading cause of cancer deaths around the world despite the availability of many approved small molecules for treatment. The issues lie in the potency, selectivity and targeting of these compounds. Therefore, new